JP2003523207A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003523207A5 JP2003523207A5 JP2001561030A JP2001561030A JP2003523207A5 JP 2003523207 A5 JP2003523207 A5 JP 2003523207A5 JP 2001561030 A JP2001561030 A JP 2001561030A JP 2001561030 A JP2001561030 A JP 2001561030A JP 2003523207 A5 JP2003523207 A5 JP 2003523207A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- liv
- polypeptide
- binds
- atcc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17795100P | 2000-01-25 | 2000-01-25 | |
| US60/177,951 | 2000-01-25 | ||
| US19576100P | 2000-04-10 | 2000-04-10 | |
| US60/195,761 | 2000-04-10 | ||
| PCT/US2001/002622 WO2001055178A2 (en) | 2000-01-25 | 2001-01-25 | Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003523207A JP2003523207A (ja) | 2003-08-05 |
| JP2003523207A5 true JP2003523207A5 (https=) | 2008-05-22 |
Family
ID=26873811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001561030A Withdrawn JP2003523207A (ja) | 2000-01-25 | 2001-01-25 | Ｌｉｖ−１関連タンパク質、それをコードするポリヌクレオチド、及び癌の治療へのその利用 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7285382B2 (https=) |
| EP (1) | EP1263780A2 (https=) |
| JP (1) | JP2003523207A (https=) |
| KR (1) | KR20020073181A (https=) |
| AU (1) | AU3458401A (https=) |
| CA (1) | CA2395832A1 (https=) |
| IL (2) | IL150592A0 (https=) |
| MX (1) | MXPA02007190A (https=) |
| WO (1) | WO2001055178A2 (https=) |
| ZA (1) | ZA200205191B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040141983A1 (en) * | 1999-03-15 | 2004-07-22 | Protein Design Labs, Inc. | Compositions against cancer antigen LIV-1 and uses thereof |
| US6762020B1 (en) | 1999-03-15 | 2004-07-13 | Protein Design Labs, Inc. | Methods of diagnosing breast cancer |
| US20030068636A1 (en) * | 2001-06-21 | 2003-04-10 | Millennium Pharmaceuticals, Inc. | Compositions, kits and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer |
| AU2003211947A1 (en) | 2002-02-20 | 2003-09-09 | Sysmex Corporation | PRIMERS FOR NUCLEIC ACID AMPLIFICATION IN DETECTING HOUSEKEEPING GENE mRNA AND TEST METHOD USING THESE PRIMERS |
| KR20050102627A (ko) * | 2003-01-27 | 2005-10-26 | 바이오겐 아이덱 엠에이 인코포레이티드 | Ｉｇｓｆ9 및 ｌｉｖ-1을 사용한 암 치료용 조성물 및치료방법 |
| WO2004067564A2 (en) | 2003-01-29 | 2004-08-12 | Protein Design Labs, Inc. | Compositions against cancer antigen liv-1 and uses thereof |
| WO2005048938A2 (en) | 2003-11-13 | 2005-06-02 | California Pacific Medical Center | Anti-pecam therapy for metastasis suppression |
| FR2863275B1 (fr) * | 2003-12-09 | 2007-08-10 | Biomerieux Sa | Procede pour le diagnostic/pronostic du cancer du sein |
| EP1709976A4 (en) * | 2003-12-26 | 2007-10-17 | Toshio Hirano | EMT-INDUCING MEDIUM |
| US7767792B2 (en) * | 2004-02-20 | 2010-08-03 | Ludwig Institute For Cancer Research Ltd. | Antibodies to EGF receptor epitope peptides |
| JPWO2005095942A1 (ja) * | 2004-03-30 | 2008-02-21 | 独立行政法人理化学研究所 | レーザーアブレーションを用いた生体試料の分析方法およびその装置 |
| EP2290087A3 (en) | 2004-12-22 | 2011-06-15 | Genentech, Inc. | Methods for producing soluble multi-membrane-spanning proteins |
| TW200813231A (en) * | 2006-04-13 | 2008-03-16 | Novartis Vaccines & Diagnostic | Methods of treating, diagnosing or detecting cancer |
| US20090258005A1 (en) * | 2007-05-29 | 2009-10-15 | Trubion Pharmaceuticals Inc. | Therapeutic compositions and methods |
| US20090304590A1 (en) * | 2007-05-29 | 2009-12-10 | Wyeth | Therapeutic compositions and methods |
| US8097423B2 (en) * | 2007-07-30 | 2012-01-17 | Institute Of Virology | MN/CA IX and breast cancer therapy |
| US20100092894A1 (en) * | 2008-10-14 | 2010-04-15 | Weihong Liu | Bottom Antireflective Coating Compositions |
| EP2496601B1 (en) | 2009-11-05 | 2017-06-07 | F. Hoffmann-La Roche AG | Methods and composition for secretion of heterologous polypeptides |
| WO2012024612A1 (en) * | 2010-08-20 | 2012-02-23 | Pangea Biosciences, Inc. | Cancer diagnostic and cancer therapeutic |
| EP2648752B1 (en) | 2010-12-06 | 2017-02-15 | Seattle Genetics, Inc. | Humanized antibodies to liv-1 and use of same to treat cancer |
| WO2013112881A1 (en) | 2012-01-27 | 2013-08-01 | Thomas Jefferson University | Mct protein inhibitor-related prognostic and therapeutic methods |
| US10022372B2 (en) | 2013-04-19 | 2018-07-17 | Thomas Jefferson University | Caveolin-1 related methods for treating glioblastoma with temozolomide |
| AU2015229035B2 (en) | 2014-03-14 | 2021-08-05 | Genentech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| MX2018010847A (es) | 2016-03-15 | 2019-07-04 | Seattle Genetics Inc | Terapia combinada mediante el uso de un conjugado de anticuerpo-farmaco de liv1 (liv1-adc) y agente quimioterapeutico. |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3040121B2 (ja) * | 1988-01-12 | 2000-05-08 | ジェネンテク，インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
| US5720937A (en) * | 1988-01-12 | 1998-02-24 | Genentech, Inc. | In vivo tumor detection assay |
| DE69031120T2 (de) | 1989-05-19 | 1998-01-15 | Genentech, Inc., South San Francisco, Calif. | Her2 extrazellulare domäne |
| CA2132500A1 (en) * | 1994-09-20 | 1996-03-21 | David Lockwood Manning | Methods for predicting the behaviour of breast tumours |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| NZ334148A (en) | 1996-08-12 | 2001-12-21 | Celgene Corp | 3-Substituted phenyl-ethyl or ethenyl derivatives terminated with a nitrile, alkane, carboxyl or carbamoyl group useful to reduce cytokine levels |
| KR20060079258A (ko) | 1996-10-18 | 2006-07-05 | 제넨테크, 인크. | 항-ＥｒｂＢ２ 항체 |
| US5860935A (en) | 1996-10-29 | 1999-01-19 | Novid Inc. | Game apparatus and method for monitoring psycho-physiological responses to questions |
| WO2001018022A1 (en) | 1999-09-03 | 2001-03-15 | Human Genome Sciences, Inc. | 52 human secreted proteins |
| CA2289116A1 (en) | 1997-05-06 | 1998-11-12 | Human Genome Sciences, Inc. | Enterococcus faecalis polynucleotides and polypeptides |
| WO1999006673A1 (en) | 1997-07-30 | 1999-02-11 | Eg & G Sealol, Inc. | Improved brush seal and method of making same |
| ZA9811162B (en) | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| DE19813839A1 (de) | 1998-03-20 | 1999-09-23 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe |
| WO1999048527A1 (en) | 1998-03-27 | 1999-09-30 | Genentech, Inc. | Apo-2 ligand-anti-her-2 antibody synergism |
| ATE386804T1 (de) | 1998-10-15 | 2008-03-15 | Novartis Vaccines & Diagnostic | Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen |
| US6579973B1 (en) | 1998-12-28 | 2003-06-17 | Corixa Corporation | Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| CA2296792A1 (en) | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
| AU3395900A (en) | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
| US6762020B1 (en) * | 1999-03-15 | 2004-07-13 | Protein Design Labs, Inc. | Methods of diagnosing breast cancer |
| US6649342B1 (en) * | 1999-03-15 | 2003-11-18 | Eos Biotechnology, Inc. | Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators |
| US20040141983A1 (en) * | 1999-03-15 | 2004-07-22 | Protein Design Labs, Inc. | Compositions against cancer antigen LIV-1 and uses thereof |
| EP1159619A2 (en) | 1999-03-15 | 2001-12-05 | EOS Biotechnology, Inc. | Methods of diagnosing and treating breast cancer |
| JP2002539816A (ja) | 1999-03-26 | 2002-11-26 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ５０個のヒト分泌タンパク質 |
| US6780586B1 (en) * | 1999-11-29 | 2004-08-24 | Protein Design Labs, Inc. | Methods of diagnosing breast cancer |
| US6750013B2 (en) * | 1999-12-02 | 2004-06-15 | Protein Design Labs, Inc. | Methods for detection and diagnosing of breast cancer |
| AU2001283463A1 (en) * | 2000-08-18 | 2002-03-04 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer and screening for cancer modulators |
| JP2005503760A (ja) * | 2001-01-24 | 2005-02-10 | プロテイン デザイン ラブス， インコーポレイテッド | 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法 |
| WO2004067564A2 (en) | 2003-01-29 | 2004-08-12 | Protein Design Labs, Inc. | Compositions against cancer antigen liv-1 and uses thereof |
-
2001
- 2001-01-25 MX MXPA02007190A patent/MXPA02007190A/es not_active Application Discontinuation
- 2001-01-25 EP EP01906709A patent/EP1263780A2/en not_active Withdrawn
- 2001-01-25 KR KR1020027009510A patent/KR20020073181A/ko not_active Ceased
- 2001-01-25 US US10/182,033 patent/US7285382B2/en not_active Expired - Fee Related
- 2001-01-25 AU AU34584/01A patent/AU3458401A/en not_active Abandoned
- 2001-01-25 JP JP2001561030A patent/JP2003523207A/ja not_active Withdrawn
- 2001-01-25 WO PCT/US2001/002622 patent/WO2001055178A2/en not_active Ceased
- 2001-01-25 CA CA002395832A patent/CA2395832A1/en not_active Abandoned
- 2001-01-25 IL IL15059201A patent/IL150592A0/xx unknown
-
2002
- 2002-06-27 ZA ZA200205191A patent/ZA200205191B/xx unknown
-
2005
- 2005-05-02 US US11/120,399 patent/US7982015B2/en not_active Expired - Fee Related
-
2006
- 2006-10-05 US US11/538,881 patent/US7691566B2/en not_active Expired - Fee Related
-
2009
- 2009-11-25 IL IL202332A patent/IL202332A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003523207A5 (https=) | ||
| KR102618312B1 (ko) | 항muc16 항체 및 그의 용도 | |
| TWI432452B (zh) | 針對ｈｅｒ-３之抗體類及其用途 | |
| JP5601836B2 (ja) | Ｔｅｓ７およびｔｅｓ７に結合する抗体 | |
| US8722362B2 (en) | Monoclonal antibodies against HER2 antigens, and uses therefor | |
| US20030086929A1 (en) | Treatment of prostate cancer by inhibitors of ATP synthase | |
| JPH04503012A (ja) | Ｃ―ｅｒｂＢ―２外部ドメイン：ＧＰ７５ | |
| JP2010537671A5 (https=) | ||
| CN115998901B (zh) | 靶向紧密连接蛋白18.2的抗体药物偶联物 | |
| MX2011004684A (es) | Anticuerpos que bloquean espicificamente la actividad biologica de un antigeno de tumor. | |
| Keydar et al. | Production and characterization of monoclonal antibodies identifying breast tumor-associated antigens. | |
| KR20080059449A (ko) | 치료용 약제 | |
| US7399469B2 (en) | Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer | |
| CA2605745A1 (en) | Cancer specific pcna isoform binding antibodies and uses thereof | |
| CA2355870A1 (en) | Reagents and methods useful for detecting diseases of the breast | |
| KR100473824B1 (ko) | 상피종의진단및치료방법 | |
| CN119343378A (zh) | 靶向itga2的抗体和包含此抗体的抗体药物缀合物 | |
| KR20100034720A (ko) | 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법 | |
| JPWO2010098503A1 (ja) | 間質性肺炎治療剤 | |
| WO2019045086A1 (ja) | 活性型もしくは潜在型ＴＧＦ−β１特異的抗体の用途 | |
| NZ233147A (en) | Retinoblastoma gene product antibodies and their use in assays for tumor cells | |
| AU2014357450B2 (en) | Antibodies targeting B-cell receptor complex membrane bound IgM and uses thereof | |
| CN113321730B (zh) | Cldn18.2抗体及其应用 | |
| US7303914B2 (en) | Monoclonal antibody against human hepatoma and use thereof | |
| CN116410305A (zh) | 一种用于检测宫颈癌病理组织中hpv16 e6蛋白的单克隆抗体 |